Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Investigating the Relationship between Graft-Versus-Host Disease Incidence and Increased Risk of Death within Three Years after Allogeneic Hematopoietic Stem Cell Transplantation in Patients Receiving Antibiotics Containing Activity Against Obligate Anaerobes

Mojtaba Akhtari, MD, Mindy Hsiao, MD

Blood (2017) 130 (Supplement 1): 4507.

https://doi.org/10.1182/blood.V130.Suppl_1.4507.4507

Published: 2017

Journal Articles

Doripenem Versus Meropenem As the First-Line Empirical Therapy in High-Risk Febrile Neutropenic Patients with Hematological Malignancy: A Randomized, Controlled Trial

Tatsuo Oyake, MD, PhD, Yuka Fujisawa, MD, PhD, Norifumi Sugawara, MD, PhD, Yasunori Nakagawa, MD, PhD, Takahiro Mine, MD, Ichiro Hanamura, MD, PhD, Maki Asahi, MD, Yukiteru Fujishima, MD, Yusei Aoki, MD, Shugo Kowata, MD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD

Blood (2014) 124 (21): 4954.

https://doi.org/10.1182/blood.V124.21.4954.4954

Published: 2014

Journal Articles

Treatment with Antibiotics Containing Activity Against Obligate Anaerobes Worsens Gvhd Survival in Mice and Humans after Allogeneic BMT

Yusuke Shono, MD PhD, Melissa D. Docampo, Odette M. Smith, Jyotsna Gupta, Sophia R. Liberman, Ying Taur, MD, Kenya Honda, MD PhD, Marcel R.M. van den Brink, MD PhD, Robert R. Jenq, MD

Blood (2014) 124 (21): 186.

https://doi.org/10.1182/blood.V124.21.186.186

Published: 2014

Journal Articles

Doripenem Versus Meropenem For Empirical Antimicrobial Therapy In High Risk Febrile Neutropenic Patients With Hematological Malignancies: A Randomized, Controlled Trial

Yuka Fujisawa, M.D., Tatsuo Oyake, M.D., Ph.D., Takahiro Mine, M.D., Yusei Aoki, M.D., Yasuhiko Tsukushi, M.D., Ph.D., Takeshi Sugawara, M.D., Masato Seguchi, M.D., Ph.D., Ichiro Hanamura, M.D., Ph.D., Yasuaki Nakagawa, M.D., Ph.D., Kazunori Murai, M.D., Ph.D., Shigeki Ito, M.D., Ph.D., Yoji Ishida, M.D., Ph.D.

Blood (2013) 122 (21): 4716.

https://doi.org/10.1182/blood.V122.21.4716.4716

Published: 2013

Journal Articles

Cefozoplan, Meropenem, or Imipenem-Cilastatin Versus Cefepime As an Empirical Therapy in High Risk Febrile Neutropenic Adult Patients: A Multicenter Prospective Randomized Trial

Takahiko Nakane, MD, PhD, Toshiharu Tamaki, Kazuo Tamura, MD, PhD, Isao Yoshida, MD, Toshihiro Fukushima, MD, PhD, Yoichi Tatsumi, MD, PhD, Yasunori Nakagawa, MD, Kazuo Hatanaka, MD, Tsutomu Takahashi, MD, PhD, Nobu Akiyama, MD, PhD, Mitsune Tanimoto, MD, PhD, Kazuma Ohyashiki, MD, PhD, Akio Urabe, MD, PhD, Tohru Masaoka, MD, PhD, Akihisa Kanamaru, MD, PhD

Blood (2012) 120 (21): 1037.

https://doi.org/10.1182/blood.V120.21.1037.1037

Published: 2012

Journal Articles

Bacteremia In Hospitalized Patients with Malignant Blood Disorders: a Retrospective Comparative Study of Causative Agents and Antimicrobial Susceptibility Profiles

Christian Karl Kjellander, MD, Honar Cherif, MD, PhD, Magnus Björkholm, MD, PhD, Mats Kalin, Md, PhD, Christian G Giske, MD, PhD

Blood (2010) 116 (21): 4868.

https://doi.org/10.1182/blood.V116.21.4868.4868

Published: 2010

NARROW

Investigating the Relationship between Graft-Versus-Host Disease Incidence and Increased Risk of Death within Three Years after Allogeneic Hematopoietic Stem Cell Transplantation in Patients Receiving Antibiotics Containing Activity Against Obligate Anaerobes

Doripenem Versus Meropenem As the First-Line Empirical Therapy in High-Risk Febrile Neutropenic Patients with Hematological Malignancy: A Randomized, Controlled Trial

Treatment with Antibiotics Containing Activity Against Obligate Anaerobes Worsens Gvhd Survival in Mice and Humans after Allogeneic BMT

Doripenem Versus Meropenem For Empirical Antimicrobial Therapy In High Risk Febrile Neutropenic Patients With Hematological Malignancies: A Randomized, Controlled Trial

Cefozoplan, Meropenem, or Imipenem-Cilastatin Versus Cefepime As an Empirical Therapy in High Risk Febrile Neutropenic Adult Patients: A Multicenter Prospective Randomized Trial

Bacteremia In Hospitalized Patients with Malignant Blood Disorders: a Retrospective Comparative Study of Causative Agents and Antimicrobial Susceptibility Profiles

Email alerts

ASH Publications

American Society of Hematology

Investigating the Relationship between Graft-Versus-Host Disease Incidence and Increased Risk of Death within Three Years after Allogeneic Hematopoietic Stem Cell Transplantation in Patients Receiving Antibiotics Containing Activity Against Obligate Anaerobes

Doripenem Versus Meropenem As the First-Line Empirical Therapy in High-Risk Febrile Neutropenic Patients with Hematological Malignancy: A Randomized, Controlled Trial

Treatment with Antibiotics Containing Activity Against Obligate Anaerobes Worsens Gvhd Survival in Mice and Humans after Allogeneic BMT

Doripenem Versus Meropenem For Empirical Antimicrobial Therapy In High Risk Febrile Neutropenic Patients With Hematological Malignancies: A Randomized, Controlled Trial

Cefozoplan, Meropenem, or Imipenem-Cilastatin Versus Cefepime As an Empirical Therapy in High Risk Febrile Neutropenic Adult Patients: A Multicenter Prospective Randomized Trial

Bacteremia In Hospitalized Patients with Malignant Blood Disorders: a Retrospective Comparative Study of Causative Agents and Antimicrobial Susceptibility Profiles

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only